Each tablet contains: Letrozole USP 2.5 mg.
A film coated, orange colour, biconvex round shaped tablet both side plain. Letrozole tablets for oral administration contains letrozole, a non-steroidal aromatase inhibitor (inhibitor of estrogen synthesis). It is chemically described as 4,4'-(1H-1,2,4-Triazol-1-ylmethylene) dibenzonitrile.
It has a molecular weight of 285.31 and empirical formula C17H11N5.
Excipients/Inactive Ingredients: Colour: Iron oxide Yellow, Sunset Yellow Lake and Titanium Dioxide.
Other Services
Country
Account